1.6 Biochemical and metabolic profiling The pathogenesis of neurodegenerative disorders generally involves a complex physiopathology that includes age-related changes, abnormal function and accumulation of brain proteins, inflammation, disruption of energy homeostasis, hormonal imbalances, metabolic imbalances, DNA damage, among other processes (Gadhave et al., 2024)
In the evolving landscape of medical weight loss, two categories of treatments have emerged as prominent: peptide therapy and GLP-1 receptor agonists
Niswender K, Pi-Sunyer X, Buse J et al (2013) Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme
Joshi GP, Abdelmalak BB, Weigel WA, Harbell MW, Kuo CI, Soriano SG, et al
180 per bottle, providing enough for a months supply
Targeting energy metabolism for autoimmune disease therapy Energy metabolism is a critical factor in the pathogenesis of autoimmune diseases, particularly in supporting the proliferation and function of activated T and B cells, which have high energy demands
